toggle navigation
Accueil
Professionnels
Etudes
Publications
Formation
Bourses et prix
Prestations
Fil infos
Patients
Adhérer à P&R
Notes médicales
Newsletters
Témoignages
Fil infos
Public
Notes médicales
Newsletters
Fil infos
Association P&R
Entreprises
Prestations
Newsletters
Fil infos
Fil infos
Contact
je fais un don
Fil infos du Groupe ACTION
INFORMATIONS COVID
+
15/04/2003
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated hepa...
En savoir plus
+
21/06/2001
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction....
En savoir plus
Prec.
1
…
46
47
Suiv.
